Press Release | Wed Feb 1, 2012 9:45pm EST

Ligand Presents Full Data from Successful Phase II Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings

* Reuters is not responsible for the content in this press release.